Your session is about to expire
Januvia vs Starlix
Introduction
For patients with type 2 diabetes, there are certain drugs that can help manage blood glucose levels by affecting the function of insulin in the body. Januvia and Starlix are two such medications often prescribed for this purpose. Both work to improve glycemic control but do so through different mechanisms.
Januvia is a type of medicine known as a DPP-4 inhibitor (dipeptidyl peptidase-4), which blocks the action of an enzyme in the body that breaks down hormones called incretins. This allows these hormones to stay in the body longer, which helps lower blood sugar by increasing insulin production and decreasing glucagon production.
Starlix, on the other hand, belongs to a class of drugs known as meglitinides. It stimulates faster insulin production from beta cells in response to meals, thus helping keep post-meal blood sugar levels under control.
Januvia vs Starlix Side By Side
| Attribute | Januvia | Starlix |
|---|---|---|
| Brand Name | Januvia | Starlix |
| Contraindications | Severe kidney disease or diabetic ketoacidosis | Type 1 diabetes or diabetic ketoacidosis |
| Cost | Around $500 for 30 tablets of 100 mg | About $230 for 60 tablets of 120 mg |
| Generic Name | Sitagliptin | Nateglinide |
| Most Serious Side Effect | Pancreatitis, signs of heart failure, severe skin reactions, low blood sugar (hypoglycemia) | Allergic reactions, severe skin reactions, unusual changes in mood or behavior, vision problems, rapid heartbeats, symptoms similar to hypoglycemia |
| Severe Drug Interactions | Not specifically mentioned, but it's important to inform the physician about all medications being taken to prevent harmful interactions | Not specifically mentioned, but similar caution advised as with Januvia regarding informing the physician about all medications being taken |
| Typical Dose | 25-100 mg/day, typically 100 mg once daily | 60 mg three times a day before meals, can be increased to 120 mg three times daily |
What is Januvia?
Sitagliptin (the generic name for Januvia) was a significant advancement in the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, used to manage type 2 diabetes. Sitagliptin was first approved by the FDA in 2006. It works by increasing levels of incretins - hormones that help control blood sugar by increasing insulin release, especially after a meal and decreasing the amount of glucose produced by the liver. Januvia is prescribed for managing blood sugar levels in adults with type 2 diabetes mellitus.
On the other hand, Nateglinide (known as Starlix), part of meglitinides class drugs, stimulates rapid and short-lasting insulin secretion to reduce post-meal high blood sugar spikes. Despite both being used for controlling hyperglycemia in type 2 diabetes, they have different mechanisms of action and side effect profiles. While Januvia has fewer gastrointestinal side effects than many antidiabetic agents due to its selective inhibition on DPP-4 enzyme, Starlix can lead to weight gain or hypoglycemia if not taken correctly around meals.
What conditions is Januvia approved to treat?
Januvia and Starlix are both approved for the treatment of type 2 diabetes:
- Januvia is often used alone or in combination with other medications to improve blood sugar control. It works by regulating the levels of insulin your body produces after eating.
- Starlix, on the other hand, is usually prescribed as part of a comprehensive treatment program including diet and exercise to control high blood sugar in people with type 2 diabetes. It helps your body respond better to insulin produced by your pancreas.
How does Januvia help with these illnesses?
Januvia works to manage diabetes by increasing the levels of incretins available in the body. Incretins are a group of metabolic hormones that stimulate a decrease in blood glucose levels. They do this by inhibiting the release of glucagon, which prevents glucose production, and enhancing insulin secretion. Insulin is a hormone that regulates blood sugar levels by allowing cells to take in sugar for energy or storage, depending on what's needed at any given time. People with type 2 diabetes have relatively lower levels of incretin effect compared to people without diabetes. Therefore, by increasing incretins, Januvia can help regulate blood sugar and support patients effectively managing their condition.
What is Starlix?
Starlix, also known as nateglinide, is an antidiabetic agent used for the treatment of type 2 diabetes. It functions by stimulating insulin production from pancreatic beta cells in response to meals, thus aiding in glucose regulation and reducing postprandial hyperglycemia (high blood sugar after meals). Starlix was first approved by the FDA in 2001. Different from DPP-4 inhibitors like Januvia which works by increasing hormones that stimulate your pancreas to produce more insulin naturally, Starlix directly prompts a rapid and short-lived release of insulin. Its unique action means its side-effect profile differs from that of DPP-4 inhibitors; it may cause hypoglycemia (low blood sugar) but less likely to cause weight gain or stomach issues - common side effects associated with drugs like Januvia. The prompt and transient increase in insulin levels can be beneficial for managing mealtime blood sugar spikes especially in patients who do not respond well to "typical" DPP-4 inhibitor antidiabetic medications such as Januvia.
What conditions is Starlix approved to treat?
Starlix, known scientifically as nateglinide, is a medication approved for the treatment of:
- Type 2 diabetes mellitus This drug helps control blood sugar levels by stimulating the body to release insulin from the pancreas. It's particularly effective in controlling postprandial hyperglycemia (high blood sugar after meals), which can be a significant issue in people with type 2 diabetes.
How does Starlix help with these illnesses?
Starlix, also known as nateglinide, is a medication that plays an essential role in the management of type 2 diabetes. It operates by stimulating the pancreas to release insulin, a hormone crucial for glucose utilization and energy production within cells. Insulin also helps lower blood sugar levels after meals by promoting its storage or use. Unlike Januvia which inhibits the enzyme DPP-4 to increase insulin production and decrease glucagon (which raises blood sugar), Starlix works more directly on pancreatic beta cells to encourage insulin release. This direct action often results in a quicker response compared to other drugs like Januvia, making it an attractive option for patients who require rapid control of post-meal blood glucose spikes.
How effective are both Januvia and Starlix?
Both sitagliptin (Januvia) and nateglinide (Starlix) are effective medications for managing type 2 diabetes, with both drugs receiving FDA approval within a few years of each other. They work via different mechanisms: Sitagliptin is a dipeptidyl peptidase-4 inhibitor that regulates the levels of insulin your body produces after eating; Nateglinide is a meglitinide analog which stimulates rapid and short-lasting release of insulin from the pancreas.
The effectiveness and safety profiles of sitagliptin and nateglinide have been directly studied in several clinical trials. One such trial found that both drugs exhibited similar efficacy in controlling blood glucose levels, although patients taking sitagliptin reported fewer side effects overall.
A review published in 2010 concluded that sitagliptin was an effective option for lowering HbA1c levels—a key measure of long-term blood sugar control—and had a favorable side effect profile compared to many other antidiabetic medications. It also noted that sitagliptin could be used as monotherapy or combined with metformin or thiazolidinediones to achieve better glycemic control.
Meanwhile, nateglinide has also proven itself as an effective treatment option for type 2 diabetes management. While it's usually considered after metformin due to its shorter duration action and need for multiple daily doses, some research indicates it may be particularly useful when combined with metformin in certain patient populations—those who require postprandial glucose control. However, more robust data supporting its use as standalone therapy is somewhat lacking compared to that available for sitagliptain.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Januvia typically prescribed?
Oral dosages of Januvia for the treatment of type 2 diabetes range from 25-100 mg/day. The typical starting dose is 100 mg once daily, and it can be taken with or without food. For patients with kidney issues, a lower dosage may be recommended by a healthcare professional. On the other hand, Starlix is typically prescribed in dosages ranging from 60 to 120 mg before meals for individuals who have type 2 diabetes. Dosage adjustments are often made based on blood glucose responses, usually within the first few weeks of treatment. Unlike Januvia, timing matters with Starlix; it should be taken no longer than half an hour before meals.
At what dose is Starlix typically prescribed?
Starlix treatment is generally initiated at a dose of 60 mg, taken orally three times a day before meals. Depending on the patient's blood glucose response, this dosage can be increased to a maximum of 120 mg three times daily. Each dose should be administered immediately before meals and if a meal is skipped, then that particular Starlix dose should also be omitted. If there is no significant improvement in glycemic control after several weeks of therapy at the maximum dosage level, then it may need to be reviewed by your healthcare provider.
What are the most common side effects for Januvia?
Common side effects of Januvia may include:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nausea
- Hypoglycemia (low blood sugar) when used in combination with certain other diabetes drugs
- Abdominal pain
Whereas, Starlix can cause:
- Hypoglycemia (low blood sugar)
- Dizziness
- Flu-like symptoms such as runny or stuffy nose, cough, and sore throat
- Back pain
Both medications are for treating type 2 diabetes. Always consult your healthcare provider to ensure the best treatment option is chosen for you.
Are there any potential serious side effects for Januvia?
When comparing Januvia to Starlix, it's important to note the potential side effects of each. In rare cases, serious side effects of Januvia can include:
- Pancreatitis marked by severe abdominal pain that extends to your back and may be accompanied by vomiting
- Signs of heart failure such as shortness of breath, rapid weight gain or swelling in hands, ankles or feet
- Severe skin reactions including redness, soreness, itching leading to a blistering and peeling rash
- Low blood sugar (hypoglycemia) symptoms like headache, dizziness, fast heartbeat
While using Starlix on the other hand,
- Hypoglycemia is also a common concern which could lead to symptoms such as sudden sweating, shaking tremors and confusion.
- Liver problems are another serious but rare effect with symptoms including yellowing eyes/skin (jaundice), dark urine or severe stomach/abdominal pain.
If you experience any aforementioned issues while taking either medication consult your healthcare provider immediately.
What are the most common side effects for Starlix?
When it comes to Starlix, patients may experience:
- Hypoglycemia (low blood sugar)
- Dizziness or light-headedness
- Headache
- Joint pain
- Flu-like symptoms such as a stuffy or runny nose and sore throat
- Changes in vision
- Unusual tiredness or weakness Remember that not everyone will experience these side effects and they are usually manageable. However, if they persist or worsen, consult your healthcare provider immediately.
Are there any potential serious side effects for Starlix?
Starlix, while effective in managing blood sugar levels, may also cause some serious side effects. The signs to watch out for include:
- Indications of allergic reaction such as hives, itching, difficulty breathing or swallowing, swelling of the face or throat
- Severe skin reactions that can involve burning sensations and a red or purple skin rash that blisters and peels
- Unusual changes in mood or behavior including confusion
- Vision problems like blurred vision, eye pain or swelling
- Rapid heartbeats which could indicate cardiovascular complications
- Symptoms similar to hypoglycemia (low blood sugar) including feelings of extreme hunger, sweating profusely, feeling shaky or nervous
If you experience any of these side effects while taking Starlix it is advisable to seek immediate medical attention.
Contraindications for Januvia and Starlix?
Just like most other diabetes medications, both Januvia and Starlix can cause hypoglycemia (low blood sugar). If you notice symptoms of low blood sugar such as sudden sweating, shaking, fast heartbeat, hunger, blurred vision or tingling in the hands/feet, seek immediate medical attention.
Januvia should not be taken if you have severe kidney disease or diabetic ketoacidosis. Similarly with Starlix, it's dangerous to use if you have type 1 diabetes or diabetic ketoacidosis. Always inform your physician about all the medications that you are taking; some drugs may require a period of clearance from your system to prevent harmful interactions with Januvia and Starlix.
Also keep in mind that while managing your diabetes medication regime is essential for maintaining good health levels; diet control and exercise also play crucial roles.
How much do Januvia and Starlix cost?
For the brand name versions of these drugs:
- The price of 30 tablets of Januvia (100 mg) averages around $500, which works out to about $16.67/day.
- The price for 60 tablets of Starlix (120 mg) is about $230, working out to approximately $3.83/day.
Thus, if you are taking one tablet per day as suggested by your doctor, then brand-name Starlix is less expensive on a per-day treatment basis than Januvia. However, please bear in mind that cost should not be the primary consideration when determining which medication is right for you.
In terms of generic equivalents:
- Sitagliptin - the generic equivalent for Januvia - costs between $400 and $450 for a month's supply or between roughly $13.33 and 15/day.
- Nateglinide - the generic version of Starlix - costs significantly less at around 0.75–$2/day depending on dosage.
Please note: Prices may vary due to location, pharmacy chosen and insurance coverage so it's recommended to check with your local pharmacist or healthcare provider before making any decisions based solely on cost considerations.
Popularity of Januvia and Starlix
Sitagliptin, in generic form as well as under the brand name Januvia, was estimated to have been prescribed to approximately 9.0 million people in the US during 2020. Sitagliptin accounted for nearly 25% of DPP-4 inhibitor prescriptions for that year. It is also one of the most commonly used antidiabetic medications not classified as a sulfonylurea or biguanide (metformin). The prevalence of sitagliptin has been generally increasing since its introduction in 2006.
Nateglinide, including brand versions such as Starlix, was prescribed to roughly half a million people in the USA in 2020. In terms of meglitinides prescription rates within the United States, nateglinide accounts for just under 10%, and less than half percent when considering overall diabetes medication prescriptions. The prevalence of nateglinide has remained fairly steady over last decade with only slight fluctuations.
Conclusion
Both Januvia (sitagliptin) and Starlix (nateglinide) have established records of usage in patients with type 2 diabetes, supported by numerous clinical studies indicating that they are more effective than placebo treatments. These two drugs can sometimes be used concurrently, but this is subject to careful consideration by a physician as their combined use may increase the risk of hypoglycemia. They work through different mechanisms of action, with Januvia primarily increasing insulin production in response to high blood sugar levels while Starlix stimulates rapid and short-lived release of insulin.
Januvia is usually considered a first-line treatment option for patients who cannot manage their blood glucose level solely through diet and exercise. On the other hand, Starlix tends to be prescribed when other oral antidiabetic medications fail or are contraindicated due its shorter duration action which requires it to be taken immediately before each meal.
In terms of cost, both drugs have generic versions available that offer significant savings especially for those paying out-of-pocket. Both Januvia and Starlix might require an adjustment period during which the optimal dosing regimen will be determined.
Side effect profiles between these two drugs vary somewhat; however both are generally well-tolerated. Common side effects include headache and dizziness for Januvia while hypoglycemia is more common in users taking Starlix due to its mechanism of action. As with any medication managing chronic conditions like diabetes mellitus, close monitoring of blood sugar levels is crucial especially at commencement or alteration in therapy.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Gadsby, R. (2007, December). New treatments for type 2 diabetes—The DPP4 inhibitors. Primary Care Diabetes. Elsevier BV.http://doi.org/10.1016/j.pcd.2007.10.004
- Umpierrez, G. E., Gianchandani, R., Smiley, D., Jacobs, S., Wesorick, D. H., Newton, C., … Pasquel, F. (2013, October 15). Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes. Diabetes Care. American Diabetes Association.http://doi.org/10.2337/dc13-0277
- Dhillon, S. (2010, March). Sitagliptin. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/11203790-000000000-00000
- Aaboe, K., Knop, F. K., Vilsbøll, T., Deacon, C. F., Holst, J. J., Madsbad, S., & Krarup, T. (2010, February 25). Twelve weeks treatment with the DPP‐4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non‐glucose induced insulin secretion in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. Wiley.http://doi.org/10.1111/j.1463-1326.2009.01167.x
- Taki, H., Maki, T., Iso, T., Iwamoto, K., & Kajiura, T. (2006, March). Study of nateglinide in Japan: Long-term treatment of patients with type 2 diabetes. Advances in Therapy. Springer Science and Business Media LLC.http://doi.org/10.1007/bf02850136